Pfizer
Rodolfo Alcántara, MBA, has held various roles in the pharmaceutical industry. From 2015 to present, they have worked at Pfizer, where they have served as the Marketing Excellence & Execution Lead, Implementation Team Lead, Transformation Director, Director / Business Unit Head - Oncology & Hematology, and Commercial Launch Excellence Lead. Prior to Pfizer, Alcántara worked at Shire as a Sr. Product Manager for LSDs & Orphan Drug Franchise, and at Roche as the Oncology Senior Manager of Product Management. Rodolfo also has experience at Bristol-Myers Squibb as a Country Product Manager and Oncology Sales Representative. Through their roles, Alcántara has demonstrated expertise in marketing, sales, product management, and team leadership.
Rodolfo Alcántara, MBA completed their Bachelor of Science in Management from Instituto Tecnológico Autónomo de México in the years 2004-2008 with a focus on Administración y gestión de empresas. Rodolfo then pursued an International Exchange program at Copenhagen Business School in 2007-2008, specializing in Marketing. In 2010, they further expanded their education by obtaining a Master's degree in Leadership from Tecnológico de Monterrey. Finally, in 2010-2012, they successfully completed their Master of Business Administration (MBA) in International Management from Instituto Tecnológico Autónomo de México.
This person is not in any offices
Pfizer
606 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.